SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001554795-14-000258
Filing Date
2014-04-01
Accepted
2014-04-01 16:05:02
Documents
1
Period of Report
2014-04-01
Effectiveness Date
2014-04-01

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 14A gnbt32514sch14a.htm DEF 14A 1087933
  Complete submission text file 0001554795-14-000258.txt   1089000
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANADA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0314
Type: DEF 14A | Act: 34 | File No.: 000-25169 | Film No.: 14734253
SIC: 2834 Pharmaceutical Preparations